Innovation Pharmaceuticals Inc (IPIX)

[Jhawker]

It’s interesting that an expert in the field endorsed the continued development of B-OM and didn’t mention anything about the ae’s. Maybe he knows more about the subject than an anonymous poster.
“ “The results of the Brilacidin OM Phase 2 are compelling,” said Company Scientific Advisor and OM expert, Stephen T. Sonis, DMD, DMSc, of Brigham and Women's Hospital. “The lack of preventive or definitive treatment options for patients at risk of, or suffering from, OM is a consistent source of patient misery and leads to costly and clinically significant downstream consequences. I enthusiastically anticipate the next phase in Brilacidin’s clinical development.”